Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Seth Fischer
AddedMar 31, 2024
UpdatedMay 31, 2026
Seth Fischer

Seth Fischer

Board Member, Agile Therapeutics

CrunchbaseLinkedIn

Seth Fischer's Career

Agile Therapeutics
Agile Therapeutics

Princeton, NJ, US

Board Member· Board
Marinus Pharmaceuticals
Marinus Pharmaceuticals

Radnor, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Seth Fischer's Career

Agile Therapeutics
Agile Therapeutics
Public$240.8M221997Princeton, NJ, US
Board Member· Board

Leadership at Agile Therapeutics

Alfred AltomariAlfred AltomariBoard Member
Ajit ShettyAjit ShettyBoard Member
John W HubbardJohn W HubbardBoard Member

Similar to Agile Therapeutics

Agile SciencesAgile SciencesRaleigh, NC, USBiopharma Solutionsest. 2007Agile SciencesRaleigh, NC, US · est. 2007

Agile Sciences: A Raleigh-based biotech firm offering commercial solutions to the biopharma industry.

Pre-Seed · $4M30
SynAgileSynAgilePiedmont, CA, USPharmaceuticals, Therapeuticsest. 2011SynAgilePiedmont, CA, US · est. 2011

SynAgile Corp, a US-based biopharmaceutical firm, innovates non-invasive therapeutics primarily for Parkinson's disease.

Public · $11.3M13
Aquestive TherapeuticsAquestive TherapeuticsWarren Township, NJ, USPharmaceuticalsest. 2004Aquestive TherapeuticsWarren Township, NJ, US · est. 2004

US-based Aquestive Therapeutics develops innovative medicines and therapeutic solutions for central nervous system diseases.

Public · $293.1M130
Applied TherapeuticsApplied TherapeuticsNew York City, NY, USDrug Developmentest. 2016Applied TherapeuticsNew York City, NY, US · est. 2016

Applied Therapeutics, a clinical-stage biotech firm, develops transformative drugs for critical medical needs in the US.

Public · $259.1M22
Marinus Pharmaceuticals
Marinus Pharmaceuticals
Public$406.9M1512003Radnor, PA, US
Board Member· Board

Leadership at Marinus Pharmaceuticals

Scott BraunsteinScott BraunsteinBoard Member
Tim MaylebenTim MaylebenBoard Member
Elan EzicksonElan EzicksonBoard Member
Harry H. PennerHarry H. PennerFounder
Harry T ReinHarry T ReinBoard Member
Nicole VitulloNicole VitulloBoard Member

Similar to Marinus Pharmaceuticals

Supernus PharmaceuticalsSupernus PharmaceuticalsRockville, MD, USPharmaceuticalsest. 2005Supernus PharmaceuticalsRockville, MD, US · est. 2005

US-based Supernus Pharmaceuticals develops and markets proprietary drugs for central nervous system disorders.

Public · $689.5M612
Marius PharmaceuticalsMarius PharmaceuticalsRaleigh, NC, USPharmaceuticalsest. 2017Marius PharmaceuticalsRaleigh, NC, US · est. 2017

Marius Pharmaceuticals: A biopharmaceutical firm innovating patient-centric therapies for hypogonadism.

Series A · $32.6M19
Sea PharmaceuticalsSea PharmaceuticalsCambridge, MA, USPharmaceuticalsest. 2013Sea PharmaceuticalsCambridge, MA, US · est. 2013

Sea Pharmaceuticals develops innovative oral treatments for neurological disorders like tinnitus and epilepsy.

Seed · $1.7M8
AptinyxAptinyxEvanston, IL, USPharmaceuticalsest. 2015AptinyxEvanston, IL, US · est. 2015

Aptinyx Inc., a US-based bio-pharmaceutical company, specializes in developing novel treatments for brain and nervous system disorders.

Public · $273.9M12

Seth Fischer's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Seth Fischer

John D TrueJohn D TrueBoard Member · Agilis SystemsPete MetrosPete MetrosBoard Member · eAgileNancy SchoendorfNancy SchoendorfBoard Member · PanasasScott SpoelhofScott SpoelhofBoard Member · eAgileRonald LennoxRonald LennoxBoard Member · Biorelix